Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies

Clicks: 338
ID: 114252
2014
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Analyzing survival in HIV treatment cohorts, Andrew Boulle and colleagues find mortality rates in South Africa comparable to or better than those in North America by 4 years after starting antiretroviral therapy. Please see later in the article for the Editors' Summary
Reference Key
boulle2014plosmortality Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Andrew Boulle;Michael Schomaker;Margaret T. May;Robert S. Hogg;Bryan E. Shepherd;Susana Monge;Olivia Keiser;Fiona C. Lampe;Janet Giddy;James Ndirangu;Daniela Garone;Matthew Fox;Suzanne M. Ingle;Peter Reiss;Francois Dabis;Dominique Costagliola;Antonella Castagna;Kathrin Ehren;Colin Campbell;M. John Gill;Michael Saag;Amy C. Justice;Jodie Guest;Heidi M. Crane;Matthias Egger;Jonathan A. C. Sterne;
Journal plos medicine
Year 2014
DOI
10.1371/journal.pmed.1001718
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.